Amgen
E850007
Amgen is a leading American biopharmaceutical company known for developing innovative therapies in areas such as oncology, nephrology, and inflammatory diseases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Amgen canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T10214730 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Amgen Context triple: [Avsola, hasManufacturer, Amgen]
-
A.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
B.
Genmab
Genmab is a Danish biotechnology company specializing in the development of antibody-based cancer therapies.
-
C.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
-
D.
Janssen Biotech
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
-
E.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Amgen Target entity description: Amgen is a leading American biopharmaceutical company known for developing innovative therapies in areas such as oncology, nephrology, and inflammatory diseases.
-
A.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
B.
Genmab
Genmab is a Danish biotechnology company specializing in the development of antibody-based cancer therapies.
-
C.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
-
D.
Janssen Biotech
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
-
E.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
public company ⓘ |
| acquired |
Horizon Therapeutics
NERFINISHED
ⓘ
Immunex NERFINISHED ⓘ Onyx Pharmaceuticals NERFINISHED ⓘ Otezla business from Celgene ⓘ |
| areaServed | worldwide ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| fieldOfWork |
bone health
ⓘ
cardiovascular diseases ⓘ hematology ⓘ inflammatory diseases ⓘ nephrology ⓘ oncology ⓘ |
| foundedBy |
George B. Rathmann
NERFINISHED
ⓘ
Joseph Rubinfeld NERFINISHED ⓘ Raymond B. Wesson NERFINISHED ⓘ William K. Bowes Jr. NERFINISHED ⓘ Winston Salser NERFINISHED ⓘ |
| foundingDate | 1980 ⓘ |
| hasResearchCenter |
Cambridge, Massachusetts
NERFINISHED
ⓘ
South San Francisco, California NERFINISHED ⓘ Thousand Oaks, California NERFINISHED ⓘ |
| headquartersLocation | Thousand Oaks, California NERFINISHED ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| ISIN | US0311621009 ⓘ |
| legalForm | corporation ⓘ |
| memberOf |
NASDAQ-100
NERFINISHED
ⓘ
S&P 500 NERFINISHED ⓘ |
| product |
Aimovig
NERFINISHED
ⓘ
Aranesp NERFINISHED ⓘ Blincyto NERFINISHED ⓘ Enbrel NERFINISHED ⓘ Epogen NERFINISHED ⓘ Kyprolis NERFINISHED ⓘ Lumakras NERFINISHED ⓘ Neulasta NERFINISHED ⓘ Neupogen NERFINISHED ⓘ Otezla NERFINISHED ⓘ Prolia NERFINISHED ⓘ Repatha NERFINISHED ⓘ Xgeva NERFINISHED ⓘ |
| specializesIn |
biologic therapies
ⓘ
monoclonal antibodies ⓘ recombinant proteins ⓘ |
| stockExchange | NASDAQ ⓘ |
| tickerSymbol | AMGN NERFINISHED ⓘ |
| website | https://www.amgen.com ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Amgen Description of subject: Amgen is a leading American biopharmaceutical company known for developing innovative therapies in areas such as oncology, nephrology, and inflammatory diseases.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.